NCT04779424 Prevalence and Incidence of Antibodies Against SARS-CoV-2 Among Primary Healthcare Providers in Belgium (COVID-19) Status COMPLETED Phase N/A
NCT04777981 (CBDRA60) to Prevent or Reduce Symptoms of COVID-19 and Prevention of Post-Acute Sequelae of SARS-CoV-2 Infection PASC Status UNKNOWN Phase NA
NCT04776317 Chimpanzee Adenovirus and Self-Amplifying mRNA Prime-Boost Prophylactic Vaccines Against SARS-CoV-2 in Healthy Adults Status COMPLETED Phase PHASE1
NCT04776044 Clinical Trial to Evaluate the Safety and Efficacy of ATR-002 in Adult Hospitalized Patients With COVID-19 Status TERMINATED Phase PHASE2
NCT04773067 A Study to Evaluate UB-612 COVID-19 Vaccine in Adolescent, Younger and Elderly Adult Volunteers Status TERMINATED Phase PHASE2
NCT04771013 Safety and Efficacy of Thymic Peptides in the Treatment of Hospitalized COVID-19 Patients in Honduras Status COMPLETED Phase PHASE2
NCT04770467 A Safety and Efficacy Study of Human Monoclonal Antibodies, BRII-196 and BRII-198 for the Treatment of Patients With COVID-19 Status WITHDRAWN Phase PHASE2
NCT04764721 Characterization in 18F-FDG PET-CT of Brain and Lung Lesions in Subjects With a History of Severe COVID-19 Status COMPLETED Phase NA
NCT04764422 Assess the Safety and Immunogenicity of NDV-HXP-S Vaccine in Thailand Status COMPLETED Phase PHASE1/PHASE2
NCT04762680 Study of Recombinant Protein Vaccines With Adjuvant as a Primary Series and as a Booster Dose Against COVID-19 in Adults 18 Years of Age and Older Status COMPLETED Phase PHASE2/PHASE3
NCT04761822 COVID19 SARS Vaccinations: Systemic Allergic Reactions to SARS-CoV-2 Vaccinations Status COMPLETED Phase PHASE2
NCT04760730 Safety and Immunogenicity Study in Adults of AZD1222 and rAd26-S Administered as Heterologous Prime Boost Regimen for the Prevention of Coronavirus Disease 2019 (COVID-19) Status COMPLETED Phase PHASE1/PHASE2
NCT04758286 Anesthetic & Surgical Protocol for Emergency Surgeries During the Era of COVID-19 Status COMPLETED Phase NA
NCT04758273 A Safety and Immunogenicity Study of Inactivated SARS-CoV-2 Vaccine (Vero Cells) in Healthy Population Aged 18 Years and Above(COVID-19) Status UNKNOWN Phase PHASE1
NCT04756830 A Study to Assess the Safety and Immunogenicity of the Coronavac Vaccine Against COVID-19 Status UNKNOWN Phase PHASE4
NCT04756518 COVID-19 Infection and Machine Learning Using Artificial Intelligence (AI) Status COMPLETED Phase N/A
NCT04756323 A Study to Evaluate Safety and Immunogenicity of Inactivated SARS-CoV-2 Vaccine (Vero Cells) in Healthy Population Aged 18 Years and Above(COVID-19) Status UNKNOWN Phase PHASE2